Clinical Trials
60 trialsExosomes in Rectal Cancer
University of Kansas Medical Center
iCaRe2
University of Nebraska
PRESERVE
Insel Gruppe AG, University Hospital Bern
RC-NAT-RWS
Beijing Friendship Hospital
ACROBATICC
Helse Stavanger HF
DEMETRA
San Raffaele University
DLARC
Sixth Affiliated Hospital, Sun Yat-sen University
A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI
Sixth Affiliated Hospital, Sun Yat-sen University
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
Mayo Clinic
ctDNA-MRD-RC
Beijing Friendship Hospital
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
Chang Gung Memorial Hospital
Registry Maastro Applicator
Maastricht Radiation Oncology
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Case Comprehensive Cancer Center
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
M.D. Anderson Cancer Center
Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Consorci Sanitari de Terrassa
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Memorial Sloan Kettering Cancer Center
MOMENTUM
UMC Utrecht
ENCODE
City of Hope Medical Center
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
SCORE
Natera, Inc.
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
West China Hospital
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
OHSU Knight Cancer Institute
ORACLE
Guardant Health, Inc.
SERENA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ADAR1TNT
Necmettin Erbakan University
DETECT
Maastricht Radiation Oncology
ADAPT
Amsterdam UMC, location VUmc
MINIGO
Qufora A/S
ARROW
Tata Memorial Centre
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery
Mater Misericordiae University Hospital
TNTRect
Universitair Ziekenhuis Brussel
RETUD
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
AWWD
Tata Memorial Centre
ctDNA
Imperial College London
Robotic Top-down Intersphincteric Resection
National Taiwan University Hospital
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
Gene Solutions
TTSS-REC
Istituto Clinico Humanitas
NOSES
Istituto Clinico Humanitas
TECARE
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
LORENA
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
PROCaRe
University Hospital Gregorio Marañón
Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)
Peking Union Medical College Hospital
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
Sunnybrook Health Sciences Centre
ART-02
Charite University, Berlin, Germany
Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
Immanuel Kant Baltic Federal University
COMREC
Peking Union Medical College Hospital
RETRY
Fondazione Policlinico Universitario Agostino Gemelli IRCCS